Evidence map›Paper›PMID 38077616›Full record

ArticlePeerJ. Computer science2023

Optimized MobileNetV3: a deep learning-based Parkinson's disease classification using fused images.

Sukanya Pechetti, Battula Srinivasa Rao

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sukanya PechettiSchool of Computer Science and Engineering, VIT-AP University, Andhra Pradesh, India.
Battula Srinivasa RaoSchool of Computer Science and Engineering, VIT-AP University, Andhra Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Parkinson's disease (PD) is a progressive neurological condition that manifests motor and non-motor symptoms. Early in the course of the disease, PD patients frequently experience vocal difficulties. In the beginning, preprocessing procedures were used with multi-focus image fusion to enhance the quality of input images. It is essential to diagnose and treat PD early to ensure that patients live healthy and productive lives. Methods: Tremors, rigidity in the muscles, slow movement, difficulty balance, and other psychological symptoms are some of the disease's symptoms. One of the critical mechanisms supporting PD identification and assessment is the dynamics of handwritten records. Several machine-learning techniques have been researched for the early detection of this disease. Yet the main problem with most of these manual feature extraction methods is their poor performance and accuracy. Results: This cannot be acceptable when discovering such a chronic condition. For this purpose, a powerful deep learning model is suggested to help with the early diagnosis of Parkinson's disease. Therefore, we proposed MobileNetV3-based classification. To enhance the classification performances even more, the MobileNetV3-based approach was optimized by the Improved Dwarf Mongoose Optimization algorithm (IDMO). Conclusion: The Pyramid channel-based feature attention network (PCFAN) chooses the critical features. The efficiency of the approaches is tested using the PPMI and NTUA datasets. Our proposed approach obtains 99.34% accuracy, 98.53% sensitivity, 97.78% specificity, and 99.12% F-score compared to previous methods.

Indexed as

Feature extractionImproved Dwarf Mongoose Optimization algorithmMobileNetV3Parkinson’s diseasePyramid channel-based feature attention network

Identifiers

PMID38077616
PMCPMC10702996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.